To address the current challenges faced by cross-border participants in clinical trials, the EU-X-CT initiative has developed general recommendations on key aspects of clinical trial management and conduct. The recommendations aim to improve safe and equitable access to cross-border clinical trials within Europe.
This document was developed in consultation with over 100 members from 32 countries. Currently in the draft stage, the recommendations will be finalized following a public consultation to ensure all stakeholder perspectives are considered.
Borders Should No Longer Be Barriers In Clinical Trials.